Medron

Medron is a South Korean biotechnology company specializing in regenerative medicine through the development of advanced hydrogel-based drug delivery systems and stem cell therapies. The company's core technology focuses on creating biocompatible scaffolds that enhance the efficacy of cell therapies and growth factors for tissue repair. Medron's pipeline includes treatments for osteoarthritis, bone regeneration, and chronic wound healing. By integrating material science with biology, the company aims to provide minimally invasive solutions for degenerative diseases. Their lead candidate, MDR-101, utilizes umbilical cord blood-derived mesenchymal stem cells encapsulated in a proprietary hydrogel for cartilage repair.